BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND PRDM16, KIAA1675, 63976, ENSG00000142611, MEL1, PFM13, Q9HAZ2
4 results:

  • 1. DNA methylation patterns suggest the involvement of DNMT3B and TET1 in osteosarcoma development.
    Pires SF; de Barros JS; da Costa SS; de Oliveira Scliar M; Van Helvoort Lengert A; Boldrini É; da Silva SRM; Tasic L; Vidal DO; Krepischi ACV; Maschietto M
    Mol Genet Genomics; 2023 May; 298(3):721-733. PubMed ID: 37020053
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways.
    Cuppens T; Moisse M; Depreeuw J; Annibali D; Colas E; Gil-Moreno A; Huvila J; Carpén O; Zikán M; Matias-Guiu X; Moerman P; Croce S; Lambrechts D; Amant F
    Int J Cancer; 2018 Mar; 142(6):1230-1243. PubMed ID: 29063609
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.
    Beck AH; Lee CH; Witten DM; Gleason BC; Edris B; Espinosa I; Zhu S; Li R; Montgomery KD; Marinelli RJ; Tibshirani R; Hastie T; Jablons DM; Rubin BP; Fletcher CD; West RB; van de Rijn M
    Oncogene; 2010 Feb; 29(6):845-54. PubMed ID: 19901961
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma.
    Man TK; Lu XY; Jaeweon K; Perlaky L; Harris CP; Shah S; Ladanyi M; Gorlick R; Lau CC; Rao PH
    BMC Cancer; 2004 Aug; 4():45. PubMed ID: 15298715
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.